| Identification | Back Directory | [Name]
2,6-Diazaspiro[3.3]heptane-2-carboxylic acid, 6-[4-bromo-6-chloro-1-[(4-fluoro-3,5-dimethylphenyl)methyl]-1H-benzimidazol-2-yl]-, 1,1-dimethylethyl ester | [CAS]
2245237-61-8 | [Synonyms]
2,6-Diazaspiro[3.3]heptane-2-carboxylic acid, 6-[4-bromo-6-chloro-1-[(4-fluoro-3,5-dimethylphenyl)methyl]-1H-benzimidazol-2-yl]-, 1,1-dimethylethyl ester | [Molecular Formula]
C26H29BrClFN4O2 | [MOL File]
2245237-61-8.mol | [Molecular Weight]
563.89 |
| Chemical Properties | Back Directory | [Boiling point ]
657.5±65.0 °C(Predicted) | [density ]
1.48±0.1 g/cm3(Predicted) | [form ]
Solid | [pka]
5.12±0.10(Predicted) | [color ]
White to light yellow |
| Hazard Information | Back Directory | [Uses]
SOS1 agonist-1 (compound 79) is an agonist for the Son of sevenless homologue SOS1. SOS1 is a guanine nucleotide exchange factor that catalyzes the exchange of GDP to GTP on RAS and regulates RAS activation. SOS1 agonists increase nucleotide exchange on RAS, enhance cellular RAS-GTP levels, and trigger biphasic signaling changes in ERK1/2 phosphorylation. Play an anti-cancer role[1]. | [References]
[1] Hodges TR, Abbott JR, Little AJ, Sarkar D, Salovich JM, Howes JE, Akan DT, Sai J, Arnold AL, Browning C, Burns MC, Sobolik T, Sun Q, Beesetty Y, Coker JA, Scharn D, Stadtmueller H, Rossanese OW, Phan J, Waterson AG, McConnell DB, Fesik SW. Discovery and Structure-Based Optimization of Benzimidazole-Derived Activators of SOS1-Mediated Nucleotide Exchange on RAS. J Med Chem. 2018 Oct 11;61(19):8875-8894. DOI:10.1021/acs.jmedchem.8b01108 |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|